Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

October 31, 2004

Study Completion Date

March 31, 2007

Conditions
Brain and Central Nervous System TumorsNeuroblastoma
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

thiotepa

DRUG

vincristine sulfate

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (13)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10021

Memorial Sloan-Kettering Cancer Center, New York

55455

University of Minnesota Cancer Center, Minneapolis

77030

University of Texas - MD Anderson Cancer Center, Houston

80218

Children's Hospital of Denver, Denver

92668

Children's Hospital of Orange County, Orange

98109

Fred Hutchinson Cancer Research Center, Seattle

90027-0700

Children's Hospital Los Angeles, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

20010-2970

Children's National Medical Center, Washington D.C.

45229-3039

Children's Hospital Medical Center - Cincinnati, Cincinnati

43205-2696

Children's Hospital of Columbus, Columbus

97201-3098

Oregon Cancer Center at Oregon Health Sciences University, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00003846 - Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors | Biotech Hunter | Biotech Hunter